
Lepu Biotechnology
Founded Year
2018Stage
IPO | IPOTotal Raised
$317.23MDate of IPO
2/23/2022Latest Lepu Biotechnology News
Jul 3, 2019
July 3 Financial Quick Takes: Mega-round for China’s Lepu; plus Citryll, Jibeier and Calliditas 2:42 PM Share Shiyu Capital leads Lepu’s $131M A round Lepu Biotechnology Co. Ltd. closed a RMB900 million ($130.7 million) series A round led by Shiyu Capital. Sumin Investment, Kaiyuan Guochuang, Suzhou Xinrui, Le Cheng Medical, and existing investor Lepu Medical Technology (Beijing) Co. Ltd. (SZSE:300003) participated in the financing. Founded last year, Lepu has PD-1 and PD-L1 inhibitors, an oncolytic virus and multiple antibody-drug conjugates (ADCs) in Phase I-III testing. Citryll raises €15M series A from Chinese and Dutch investors Citryll B.V. (Oss, the Netherlands) raised €15 million ($16.9 million) in a series A round from ModiQuest B.V. (Oss, the Netherlands), BOM Brabant Ventures, the BrightGene International (Hong Kong) Ltd. unit of BrightGene Bio-medical technology Co. Ltd. (Suzhou, China) and Curie Capital. The company is developing antibodies that block the formation of neutrophil extracellular traps by binding to N-terminal citrullinated epitopes in histones, which could treat autoimmune diseases such as lupus and rheumatoid arthritis. Jibeier looks to list in Shanghai The Shanghai Stock Exchange accepted an application from Jiangsu Jibeier Pharmaceutical Co. Ltd. (Zhenjiang, China) to list on its new science and technology innovation board. The company proposed to raise up to RMB690 million ($100.2 million). The pharma develops chemical preparations and traditional Chinese medicines. Calliditas raises $22.6M A year after going public on NASDAQ Stockholm, renal disease company Calliditas Therapeutics AB (SSE:CALTX) raised SEK210.3 million ($22.6 million) through the sale of 3.5 million shares at SEK60 in a private placement. Investors included BVF Partners L.P. (see "Calliditas Raises Over $70M in Swedish IPO" ). User Sign in
Lepu Biotechnology Frequently Asked Questions (FAQ)
When was Lepu Biotechnology founded?
Lepu Biotechnology was founded in 2018.
Where is Lepu Biotechnology's headquarters?
Lepu Biotechnology's headquarters is located at 2nd Floor, Building 41, No. 518, Xinzhuan Road, Songjiang District, Songjiang District.
What is Lepu Biotechnology's latest funding round?
Lepu Biotechnology's latest funding round is IPO.
How much did Lepu Biotechnology raise?
Lepu Biotechnology raised a total of $317.23M.
Who are the investors of Lepu Biotechnology?
Investors of Lepu Biotechnology include Vivo Capital, Shanghai Biomedical Industry Equity Investment Fund Management, Sunshine Riverhead Capital, Ping An Capital, Sunshine Insurance Group and 11 more.